A team of researchers led by Xiaoguang Dong, assistant professor of mechanical and biomedical engineering at Vanderbilt University, have developed a magnetic robotic valve to provide minimally invasive intervention for gastroesophageal reflux disease and possibly other organ system disorders.
Pneumonia remains one of the leading causes of death in low- and middle-income countries, where access to advanced medical technologies is limited. According to the World Health Organization, acute lower respiratory tract infections such as pneumonia continue to place an immense burden on health systems in these regions.
EPFL researchers have invented a remarkably small and ultraflexible neurovascular microcatheter. Powered by blood flow, it can safely navigate the most intricately branched arteries in a matter of seconds.
Diane Chan, a former research scientist in The Picower Institute for Learning and Memory and neurologist at Massachusetts General Hospital, is the study’s lead and co-corresponding author. Picower Professor Li-Huei Tsai, director of The Picower Institute and the Aging Brain Initiative at MIT, is the study’s senior and co-corresponding author.
Medtronic (NYSE: MDT)+
today announced the launch of its Stedi extra support guidewire for use with its Evolut TAVR platform.
Blood tests are among the most common tools in medicine. Scientists are working to make blood cell imaging faster and more intuitive so that doctors can make fast and accurate diagnostic decisions.
BEAVERTON, Ore., Oct. 24, 2025 /PRNewswire/ — YorLabs, Inc., a medical technology company pioneering next-generation intracardiac imaging solutions for electrophysiology (EP) and interventional cardiology (IC) procedures, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s YorLabs Intracardiac Imaging System – a first-of-its-kind, zero-capex ultrasound platform designed to simplify workflow, reduce cost, and enhance procedural efficiency inside the cath lab.
The tool integrates with the current laboratory infrastructure, captures images of embryos and creates an AI score.
The device has shown to be advantageous for individuals with neurological or orthopaedic disorders.
The expanded FDA clearance makes NeurAxis’ IB-Stim the first FDA approval for a treatment that specifically addresses functional dyspepsia.